Inaktiver Wert

Andere Sprachen Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE

Aktien

Clal Biotechnology Industries Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	31.03.
Clal Biotechnology Industries Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	16.08.23
Clal Biotechnology Industries Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	23.05.21
Clal Biotechnology Industries Ltd. announced that it expects to receive ILS 24.999999 million in funding from Meitav Dash Providence and Pension Ltd.	11.07.17
Clal Biotechnology Industries Ltd. announced that it expects to receive ILS 5 million in funding	12.04.17
Clal Biotechnology Industries Ltd. announced that it expects to receive ILS 20 million in funding from Yelin Lapidot Provident Funds Management Ltd., Yelin Lapidot - Mutual Funds Management Ltd.	09.04.17
Clal Biotechnology Seeks Investments	04.04.17
Clal Biotechnology Industries Ltd. Appoints Ofer Gonen as Permanent CEO	07.03.17
Clal Biotechnology Industries Ltd. Appoints Julian Adams Ph.D. as President and Chief Science Officer	23.01.17
Investment Arm of Cybele Investment House Ltd and Investment Arm of Victor Tshuba & Co. Law Office acquired 58% stake in D-Pharm LTD. from Clal Biotechnology Industries Ltd. for ILS 0.31 million.	06.09.16

Keine Ergebnisse zu dieser Suche